Insider Transactions in Q1 2023 at Kura Oncology, Inc. (KURA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2023
|
Teresa Brophy Bair Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,125
+50.0%
|
-
|
|
Feb 16
2023
|
Thomas James Doyle SVP, Finance & Accounting |
BUY
Grant, award, or other acquisition
|
Direct |
10,625
+27.89%
|
-
|
|
Feb 16
2023
|
Stephen Dale Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,125
+31.28%
|
-
|
|
Jan 27
2023
|
Kathleen Ford Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,821
-7.91%
|
$23,673
$13.89 P/Share
|
|
Jan 27
2023
|
Kirsten Flowers CCO & Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,906
-8.47%
|
$24,778
$13.89 P/Share
|
|
Jan 27
2023
|
Stephen Dale Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,225
-13.38%
|
$119,925
$13.88 P/Share
|
|
Jan 27
2023
|
Thomas James Doyle SVP, Finance & Accounting |
SELL
Open market or private sale
|
Direct |
1,548
-4.3%
|
$20,124
$13.89 P/Share
|